Long-Term Adjunctive Edaravone for ALS: Latest Findings Long-Term Adjunctive Edaravone for ALS: Latest Findings

Adding IV edaravone to riluzole for a year provides no additional benefit in terms of amyotrophic lateral sclerosis progression, time to ventilation, or survival versus riluzole alone, new research shows.Medscape Medical News

Source: Medscape Neurology and Neurosurgery Headlines - January 17, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news